ABOUT APCRAAPCRA Limited is a clinical research organisation, based in Hong Kong,

that provides clinical trial, quality assurance & clinical research training services throughout the Asia Pacifc region.


With a precise blend of clinical trial knowledge, talent and resources APCRA provides high quality, cost effective clinical trial management, quality assurance and training services to clients.


APCRA’s flexibility helps us optimise functionality and improve operational efficiencies for any clinical trial and our reputation for providing and conducting clinical trials within the APAC region is based not only on our past performance, but also from the positive feedback and repeat service we receive from our clients.


If required, we work with associates who are distinguished not only by their clinical trial, technical expertise and therapeutic backgrounds, to ensure that our clients’ clinical trials are conducted to the highest quality and professional standards.


  • The China National Drug Administation (CNDA) has announced that it will expedite approval of drugs developed overseas that are in urgent demand domestically.
    For full information click here

  • Last month (May 2018), the China National Drug Administration (CNDA)released a draft rule on Inspection Key Points and Guiding Principles of Medical Device Clinical Trials (“New Draft”).
    For full information click here

  • On May 1, 2018, the Chinese Government eliminated imported drug tariffs on 28 categories of imported drugs.
    For full information click here

  • APCRA Limited is pleased to announce their partnership with AstraCrux Clinical Research Consulting Inc. in Taipei, Taiwan.
    Click here for press release

  • Protecting the accuracy of clinical trial data in China'The Chinese government has signalled its commitment to ensure the quality of clinical trials conducted in China.
    For full information click here